On March 2, 2020, a 69-year-old White, Hispanic woman with a chief complaint of respiratory distress (began on 3/1) and a 2-day history of fever, dry cough, sore throat, fever, and diarrhea was admitted to the ED.
She experienced severe respiratory comprise, was transferred to the MICU and placed on mechanical ventilation. 
Lab tests resulted in a positive (Observation) for SARS-CoV-2. Primary diagnosis: COVID-19. Secondary diagnosis: COPD, diabetes, hypertension. 
Meds from home (prior to 3/2) included: metformin, insulin, atorvastatin, and albuterol. 
The patient was treated with ceftriaxone (2 gm IV q.d), hydroxychloroquine po (400 mg b.i.d for the 1st day and 200 mg b.i.d afterwards), potassium 80 mEq IV qd. 
On day 3 of hospitalization, patient experienced QT prolongation (Observation resource -> adverse event on reporting spreadsheet), possibly related to hydroxychloroquine(NA?). 
Hydroxychloroquine was discontinued and tocilizumab 400 mg started. Patient improved after 12 days and was discharged to home on March 14, 2020. 
Labs were negative on last day for SARS-CoV-2 and influenza.

Resource instances:
http://hapi.fhir.org/baseR4/Patient/PT-707
http://hapi.fhir.org/baseR4/Encounter/EN-707
*Note- Encounter.class updated from Emergency to Inpatient and dischargeDisposition added upon final update
http://hapi.fhir.org/baseR4/Condition/CO-707
http://hapi.fhir.org/baseR4/Condition/CO-708
http://hapi.fhir.org/baseR4/Condition/CO-709
http://hapi.fhir.org/baseR4/Condition/CO-710
http://hapi.fhir.org/baseR4/Condition/CO-711
http://hapi.fhir.org/baseR4/Procedure/PR-707
http://hapi.fhir.org/baseR4/Observation/covid-pos
http://hapi.fhir.org/baseR4/MedicationRequest/MR-707
http://hapi.fhir.org/baseR4/MedicationRequest/MR-708
http://hapi.fhir.org/baseR4/MedicationRequest/MR-709
http://hapi.fhir.org/baseR4/MedicationRequest/MR-710
http://hapi.fhir.org/baseR4/MedicationRequest/MR-719
http://hapi.fhir.org/baseR4/MedicationRequest/MR-711
http://hapi.fhir.org/baseR4/MedicationRequest/MR-712
http://hapi.fhir.org/baseR4/MedicationRequest/MR-720
http://hapi.fhir.org/baseR4/Condition/CO-715
http://hapi.fhir.org/baseR4/Condition/CO-716
http://hapi.fhir.org/baseR4/Condition/CO-717
http://hapi.fhir.org/baseR4/Condition/CO-718
http://hapi.fhir.org/baseR4/Observation/QT-prolong
http://hapi.fhir.org/baseR4/MedicationRequest/MR-730
http://hapi.fhir.org/baseR4/Observation/covid-neg
http://hapi.fhir.org/baseR4/Observation/flu-neg
